成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Drug metabolism letters >>article

Drug metabolism letters

Download PDF

Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats.

Published:1 January 2015 DOI: 10.2174/1872312809666150602151922 PMID: 26031461
Ben-Quan Shen, Daniela Bumbaca, Qin Yue, Ola Saad, Jay Tibbitts, S Cyrus Khojasteh, Sandhya Girish

Abstract

DM1, a derivative of maytansine, is the cytotoxic component of the antibody-drug conjugate trastuzumab emtansine (T-DM1). Understanding the disposition and metabolism of DM1 would help to assess (1) any tissue-specific distribution and risk for potential drug-drug interactions and (2) the need for special patient population studies. To this end, the current study determined the disposition and metabolism of DM1 following single intravenous administration of [(3)H]-DM1 in Sprague Dawley rats. Blood, tissues, urine, bile, and feces were collected up to 5 days after dose administration and analyzed for total radioactivity and metabolites. Results showed that radioactivity cleared rapidly from the blood and quickly distributed to the lungs, liver, kidneys, spleen, heart, gastrointestinal tract, adrenal glands, and other tissues without significant accumulation or persistence. The majority of dosed radioactivity was recovered in feces (~100% of the injected dose over 5 days) with biliary elimination being the predominant route (~46% of the injected dose over 3 days). Excretion in urine was minimal (~5% of the injected dose over 5 days). Mass balance was achieved over 5 days. An analysis of bile samples revealed a small fraction of intact DM1 and a predominance of DM1 metabolites formed through oxidation, hydrolysis, S-methylation, and glutathione and its related conjugates. Collectively, these data demonstrate that DM1 is extensively distributed and quickly cleared from blood, and undergoes extensive metabolism to form multiple metabolites, which are mainly eliminated through the hepatic-biliary route, suggesting that hepatic function (but not renal function) plays an important role in DM1 elimination.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Maytansine 35846-53-8 C34H46ClN3O10 74 suppliers Inquiry
Trastuzumab emtansine 1018448-65-1 37 suppliers Inquiry
DM1 Impurity2 936481-22-0 C35H48ClN3O10S 7 suppliers Inquiry
DM1 28020-80-6 C27H29NO10 - Inquiry

Similar articles

IF:2.7

Pharmacokinetics of Memantine after a Single and Multiple Dose of Oral and Patch Administration in Rats

Basic & Clinical Pharmacology & Toxicology Soo-Han Lee, Seung-Hyun Kim,etc Published: 27 August 2015